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Introduction
Healthcare expenditures are rising worldwide and endanger the affordability of national healthcare systems. [1, 2] To secure their future existence, a thoughtful and righteous distribution of limited resources is essential. Policy makers and healthcare professionals are therefore increasingly expected to study the effectiveness of treatments and its associated costs. [3, 4] After all, the input from high quality cost research is required to make healthcare systems efficient and to achieve the highest quality of care for the lowest costs. [5] Also in the field of traumatic brain injury (TBI), with an estimated total global annual burden of US$ 400 billion, research efforts are increasingly conducted towards cost-effectiveness. [6] [7] [8] [9] [10] After sustaining a TBI, in-hospital treatment is frequently required and generally associated with high costs. [11] [12] [13] [14] In the USA, the 2010 TBI-related in-hospital charges totalled US$ 21.4 billion. [15] In-hospital costs after TBI are increasing annually and represent a substantial part of the total financial TBI burden. [15] The highest individual costs in TBI patients are generally seen in patients with severe TBI (s-TBI). [16] These patients also have the longest hospital or intensive care unit (ICU) length of stay (LOS) and the highest number of (neuro)surgical and medical interventions. [16] [17] [18] Despite their substantial healthcare consumption, these vulnerable patients show high rates of mortality and unfavourable outcome. Especially for these patients with poor outcome at high costs, a critical appraisal of treatment costs-effectiveness is essential to avoid ineffective expenditures and improve treatment decision-making. [19] [20] [21] [22] Two recent reviews on healthcare costs after TBI have reported about the considerable variation in healthcare costs after TBI between different studies and about the insufficient quality of the available cost studies. [7, 10] These reviews however were mainly focussed on the methodological quality of economic evaluations and therefore did not report the actual in-hospital costs. Insight into in-hospital costs and important components of the costs, such as healthcare utilization and other factors that drive these costs were not provided. This is important information for physicians and policymakers, because this information is needed for decision-making and for correct allocation of resources.
In this systematic review, we have therefore focussed on: (1) providing a detailed insight in the reported in-hospital costs for patients with s-TBI and (2) assessing the (quality of) study methodology.
Methods
This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
[23] (S1 Table) The study protocol was registered in the PROSPERO International Prospective Register of Systematic Review with registration number CRD42018081131.
Emcare, PsychINFO, Academic Search Premier and Google Scholar. The search strategy was developed and conducted with the assistance of a trained clinical librarian. All relevant information on the literature search can be found in S1 Appendix. In addition to the search, the reference lists of all included articles were manually checked for additional relevant studies.
Inclusion/Exclusion criteria
Studies were included when the in-hospital costs or in-hospital charges of a cohort of >10 patients with s-TBI were reported. Because the appellation "severe TBI" encompassed a range of brain injuries considered to be too varied for appropriate comparison the two most widely used classifications for s-TBI were applied: Glasgow Coma Scale (GCS) �8 and/or Abbreviated Injury Scale (AIS) �4. [24-26] We excluded reviews, commentaries, editorials, conference and meeting abstracts, unpublished data, non-English studies and studies that could not be found or retrieved in full text. Studies were also excluded when in-hospital costs related to acute care were not distinguishable from other costs like indirect non-healthcare related costs (e.g. loss of productivity), (in-hospital) rehabilitation or long-term costs. There were no restrictions on publication date or patient characteristics.
Article selection and data extraction
First, duplicates, non-English and unretrievable records were excluded. Second, two reviewers (JD,MD) independently screened the titles and abstracts of the remaining studies and selected all potential eligible studies. Full-texts were independently reviewed by the same researchers and studies were included according to the above mentioned criteria. During the process, all disagreements were resolved through discussion until consensus or after consulting a third researcher (RO). Data extraction was performed in duplicate using pre-created data extraction sheets. Extracted data was then discussed and combined. Variables that were collected included: study details, study population, definition of TBI (including severity), healthcare consumption, details of costs research methodology and cost outcome results.
Quality assessment
A 19-item checklist was used to assure an accurate quality assessment for the evaluation of inhospital costs following s-TBI. The checklist was based on the CHEERS statement, which is developed to improve the reporting on economic evaluations. [27-30] We slightly adjusted the items from the CHEERS statement by specifying items like 'target population and subgroups' in clear definition of illness and TBI severity, because this was deemed necessary for proper interpretation of study results. Also we intentionally left out items like cost perspective, time horizon and discounting costs since these were considered not relevant for short term in-hospital costs. The final checklist covers items in the areas of study details, population, clinical data, cost data and study methodology. All relevant details can be found in S2 Appendix.
The quality assessment was independently performed by three reviewers (JD, MD, RO). Disagreements were reassessed and discussed in several meetings until consensus was reached. All items were scored according to a predefined scoring manual that included four options: yes (1), suboptimal (0.5), no (0) and not applicable (N/A). A double weight was assigned to several items that were considered to be particularly important in calculating and reporting inhospital costs. Final scores represented study quality and were presented as a percentage of the maximum score per study. Scores per item and item category were also calculated. All items that were not applicable were excluded from score calculation. When studies used a statistical model, items were scored considering the clear use and description of the model input parameters and sources.
Outcome
All relevant data was reported in a descriptive manner. In line with the inclusion criteria, patients were included from three different severity groups as they were reported in the included studies (GCS�8, AIS�4, AIS�5). These subgroups were also used in the text and figures. In one figure, hospital LOS was presented by using black indicators (■) and ICU LOS by white indicators (□). A clear distinction between hospital costs and hospital charges, when known, was made by using black and white indicators respectively. In-text, both the reported hospital charges and hospital costs were presented as in-hospital costs. The Gross Domestic Product (GDP) per capita of the study country was included as reference value, to improve comparability between the reported costs. The reference year that was used, corresponded with the currency year. 
Results

Literature search and study selection
The systematic literature search identified 2372 studies (Fig 1) . First, a total of 283 duplicate, non-English or unfindable studies were removed. The remaining 2089 studies were screened on title and abstract, resulting in 204 studies considered eligible for full-text assessment. Studies were excluded because; (1) they did not include a s-TBI cohort defined by a GCS�8 and/or AIS�4 (N = 134), (2) they did not report hospital costs for patients with s-TBI (N = 28) or (3) in-hospital acute care costs were not distinguishable from other costs (N = 13). No additional studies were identified through the reference check. Ultimately, 25 articles were included in this systematic review.
Study characteristics
The main study characteristics can be found in Table 1 . Twelve studies were published after 2010, nine between 2000 and 2019, and four before 2000. Cohort size ranged from 20 to 7774 patients. [34, 35] Nineteen studies were conducted in high income countries of which sixteen in the USA. The majority of studies focused on adult patients, while some studies focused on paediatric [34, 36-38] and elderly patients. [35, 39] Nineteen studies (76%) had cost research in TBI patients as a research objective. TBI was often only defined by mentioning "TBI" or "head injury" (N = 9). Six studies provided only little additional information and nine studies used ICD (N = 8) and/or AIS codes (N = 2). Severity was defined by GCS (68%), by AIS (28%) or both (4%). The used GCS was obtained at admission (n = 7), the emergency department (n = 3) and the time remained unknown in 5 studies. A retrospective study design was used in 60% [35-37, 39-50], followed by a prospective design (16%) [34, [51] [52] [53] or a combination of both (12%). [54] [55] [56] Three studies used a statistical model. [38, 57, 58] 
Quality of study methodology
The results of the quality assessment are presented in detail in S2 Table. Study quality was variable with an average total score of 71% and a range of 48% to 96%. Seven studies achieved a score above 80%, representing "high quality". [36, 38, 39, 47, 50, 53, 58] Especially items in the 'cost data' subgroup scored poorly (49%). All but one study mentioned their cost data source, When available, severity defined by GCS was further specified by adding the mean GCS but a clear description was missing in 24%. Also, the design and methods of costs analysis were not mentioned in 36% and were unclear in another 16%. Eleven studies properly assessed hospital activity data but only three studies appropriately valued and reported unit costs. Hospital costs were disaggregated in 20% of studies and in 52% charges were reported instead of costs. Major assumptions were tested in a sensitivity analysis in only 16% and a reference year was missing in 14% of the studies. The subgroups 'study details', 'population' and 'methodology' had the highest scores (100%, 87% and 78%). There were infrequent statements on source of funding and conflicts of interest, unsatisfying TBI definitions and inadequate evaluation of study findings.
Hospital costs & healthcare consumption
The median reported in-hospital costs per patient were $55,267 (mean $87,634) and ranged from $2,130 to $401,808 (Fig 2) . The lowest costs were seen in studies from China, Pakistan [47, 52] and 11 to 17.5 days (AIS�5). [46, 47] Some studies reported costs related to acute care to be 46% to 67% of total hospitalization costs, while inpatient rehabilitation costs accounted for 26% to 41%. [41, 42, 54, 57] Various studies found that costs related to hospital LOS and ICU LOS were the main drivers of hospital costs. [36, 38, 39, 47, 50, 53] Costs related to ICU care comprised the biggest part of total hospital costs (51-79%), followed by costs related to ward admission (12-38%), surgery (4-8%) and imaging/laboratory (<3%). [36, 38, 47] Physician charges were reported to be 12% to 20% of total costs. [39, 41] One study included the salary of paramedics and found salary to be the most important contributor (71-79%) to total provider costs. [39, 41, 51] The majority of costs, up to 90%, were made in the first year after trauma and were generally associated with TBI-related hospitalization costs. [41, 48, 57] The share of acute hospital services (18%) and rehabilitation (27%) on total costs decreased when a long-term follow-up period was used. [52] Several studies provided some additional information on clinical factors that were associated with reported costs. A higher TBI severity was generally related with an increased LOS and costs. [35, 39, 53] and two studies mentioned that a higher age was more expensive. [47, 50] Costs were also influenced by trauma mechanism and were higher for motor vehicle accidents and gunshot wounds and lower after an assault to the head. [34, 35, 39, 46, 53, 54] The use of surgical intervention, intracranial pressure monitoring or mannitol were all related to longer LOS and higher costs. [37, 38, 45, 53, 54] Also, the introduction of guidelines and evidence based medicine protocols appeared to increase LOS and hospital costs [43, 55] , while improvement of guideline adherence did not change ICU and hospital costs in another study.
[36] Three studies related costs to outcome and found lower costs for patients that died or made a good recovery. [37, 53, 58] 
Discussion
This systematic review demonstrates that the in-hospital costs related to acute care for patients with s-TBI are generally high and increase with severity of TBI and overall severity of the injury. Both healthcare consumption and in-hospital costs are highly variable between studies and associated with factors such as mechanism of injury and treatment strategy.
Three previous reviews on costs after TBI were generally in line with our results, but results were difficult to compare with the present review due to differences in study objectives and substantial variation between the included studies that was mainly caused by differing methodological and clinical characteristics. [7, 59, 60] Elaborating on these reviews, we specifically investigated the in-hospital costs related to acute care for patients with s-TBI aiming to reduce variation and improve study comparability. Methodological and clinical heterogeneity remained present, likely contributing to the variation in in-hospital costs between studies. The highest in-hospital costs were found in studies from the USA that reported charges instead of costs. Because hospital charges are not actual costs and usually higher than hospital costs, this increased total amounts. Charges are also often non-transparent and the resultant of deals between hospitals and insurance companies or other stakeholders. It is therefore preferred to calculate and report total costs by using healthcare utilization with its corresponding unit costs. Also, USA healthcare expenditures are twice as high as expenditures in other highincome countries. [2, 61] While healthcare utilization patterns were rather similar between high-income countries, the higher expenditures were especially caused by higher prices of labour, goods, pharmaceuticals and administrative costs. [2, 62] Large international differences were also seen between European countries when assessing injury related hospitalization costs. [63] Likewise, the lowest in-hospital costs were found in studies from lower-income countries, which is also in accordance with literature. [64] These absolute costs are lower because of lower prices, lower treatment intensity and higher mortality rates with associated lower resource utilization. [64, 65] In-hospital costs reported as percentage of GDP per capita were however not significantly different between high and low income countries, suggesting a similar financial impact for patients. Differences in costs might also be caused by hospital associated factors (e.g. level of trauma center, volume, treatment protocols) and by the major epidemiological differences of trauma populations between countries. [6] The different timeframes included in this review could also contribute to variation, since treatment strategies have changed over time and healthcare costs have been increasing globally over the years. [15, 64, 66] Comparing in-hospital costs from different healthcare systems in different timeframes is therefore problematic.
As in literature, the identified in-hospital costs increase with higher TBI severity. [9, 16, 60, 67] Costs increase because they primarily consist of costs related to LOS and surgical interventions and because the utilization of both is higher in more severely injured TBI patients. [68] [69] [70] [71] After all, healthcare expenses are equal to utilization multiplied by associated prices. [62] Also in other studies, physician charges are another important contributor to in-hospital costs. [2, 72] Length of stay results and its variability seemed to be in accordance with literature, but were difficult to compare due to this variation. [68, 69] Like in previous research, extracranial injuries and overall injury severity contributed to higher healthcare consumption and in-hospital costs. [67, 69, [73] [74] [75] Distinguishing costs that are related to TBI or associated extracranial injuries is nearly impossible. Therefore, four studies explicitly investigated patients with isolated-TBI. [44, 51, 53, 56] Motor vehicle accidents and gunshot wounds were reported to be related to higher costs, most likely because of higher injury severity and accompanying extracranial injuries. Although a higher age is often considered to be more expensive, only few studies mentioned this and comparison between the age groups did not show obvious differences in LOS or in-hospital costs. [15, 63, 67, 73] Hospital and acute care costs were reported to be important constituents of total costs followed by in-patient rehabilitation. However, the limitations of a short follow-up period have been recognized before. [7] Although the in-hospital costs are obviously an important part, post-discharge rehabilitation and other long term care costs are also major contributors to the total costs after TBI. [12] When including the enormous long-term or lifetime costs and the loss of productivity, the share of in-hospital costs on the total burden significantly decreases. [12, 14, 76] A long-term follow up period would provide a better overview for two reasons. First, the assessment of patient outcome will be more accurate, because health problems might persist, improve or deteriorate several years after trauma. [77, 78] Second, the cost analysis will be more comprehensive, since a changing health situation influences healthcare consumption and productivity for both patients and relatives. Therefore, especially for establishing the costeffectiveness of treatments, a long-term follow-up should be included.
The identified most important reasons for (outcome) variation were probably all caused by different study objectives. Study objectives determined study methodology and consequently also the studied participants, interventions and outcome. Although most study objectives included costs research, the major differences between them likely caused the aforementioned methodological and clinical heterogeneity. Heterogeneity has earlier been reported for TBI cost studies and complicates study comparison and outcome interpretation. [7, 10, 59, 60] Heterogeneity is not limited to TBI cost research, but is very common in general TBI research and likewise complicates comparability, generalizability and interpretation of other studies. [79] [80] [81] [82] Study quality also influenced interpretation of study results, since poor methodological quality compromises quality and therefore value of data. Two recent reviews specifically assessed the methodological quality of TBI cost evaluation studies and identified important limitations regarding the adherence to the methodological principles of economic evaluations. [7, 10] More specifically, these limitations include not reporting all relevant costs on a longterm or lifetime horizon, not discounting future costs, not performing incremental analysis of cost-effectiveness and applying sensitivity analysis. Our quality assessment found variable and overall inadequate study quality. Only few studies were considered high quality and especially items concerning the calculation and reporting of costs scored poorly. Cost results were often provided without relevant context. A description of costs analysis methods, required to understand and interpret the results, was frequently missing. Studies also rarely calculated in-hospital costs by transparently multiplying healthcare consumption with associated unit costs. Almost no study reported the highly informative and important disaggregated costs. Even reference years were missing in several studies. Because several studies did not focus on reporting costs after TBI, they might have scored low on our quality assessment, despite appropriately investigating their specific study objectives.
Strengths and limitations
This systematic review benefits from an extensive literature search in multiple databases and strict inclusion criteria, which improve study comparability and interpretation of results. The PRISMA guidelines were used during the review process and the quality assessment made use of a checklist that was based on the CHEERS statement and allowed the critical appraisal of the included articles. Although the assignment of scores is partly subjective, our experiences regarding the quality assessment using this checklist were positive. In addition, this is by our knowledge, the first detailed overview of in-hospital costs in patients with s-TBI.
This study also has several limitations. The article selection criteria resulted in the exclusion of some patients, that were severely injured but lacked the required severity classification. Also, regarding in-hospital costs, studies were excluded that not clearly distinguished acute care in-hospital costs from rehabilitation costs, indirect costs or other non in-hospital costs. Data from these patients could have contributed to our results, but the introduction of additional methodological and clinical heterogeneity would have compromised comparability and interpretation of study results. In addition, the used TBI severity criteria have their limitations. The GCS has been criticized for its general applicability although it shows adequate reliability in a recent review. [24, 83] A patient can be scored 'false-low' due to intubation and sedation overestimating injury severity, while the severity of patients who quickly deteriorate after admission will be underestimated. Also, a decreased GCS is not always caused by TBI and could also be caused by extracranial injury alone. [84] Last, patients could be at the lower or the higher end of the spectrum within the GCS 3-8 group. This could have substantial impact on study results, because severity is related to costs. Regarding AIS, the classification system changed over time and the 2005 version codes similar injuries with a lower severity score compared to the 1998 version. [85] Also, some researchers suggest using AIS�5 as severe, instead of AIS�4. [86] Despite this, using both criteria is very relevant because they are the most widely used criteria for s-TBI.
[24] Limiting the selection to patients with s-TBI improves comparability, but fails to assess the financial burden caused by minor and/or moderate TBI. Although individual costs are lower for these injuries, the total burden on society is much higher because of their more frequent occurrence. [16] Although the distinction is clearly made throughout, including hospital charges and hospital costs may have compromised comparability of study results. Since both are frequently reported, it did however make a comprehensive review of in-hospital expenses possible and points out the difficulty of cost research. Last, the focus on in-hospital costs, dramatically underestimated the total financial burden caused by s-TBI. [12, 14, 76] 
Future research
Because a righteous and ethical distribution of limited healthcare resources is essential to secure the future existence of successful healthcare systems around the world, policymakers increasingly request high quality evidence regarding the cost effectiveness of treatments. [3] To improve the future quality of TBI cost research, investigators should equalize methodological and clinical heterogeneity by using specific methodological guidelines and common data elements. [27, 87] As seen in this systematic review, one of the biggest challenges in TBI cost research is heterogeneity. Checklists could be helpful, but the development of international guidelines on economical evaluations for TBI patients is preferred. Patient outcome should be investigated along with the financial burden of treatments. Therefore, cost-effectiveness analysis should be included in upcoming trials investigating TBI treatment strategies. Patients from all ages should be investigated because all are confronted with the consequences of TBI. Because TBI related consequences and associated costs are variable over time, economic evaluations should include a long-term or even lifetime horizon. [6] All associated costs adding to the total burden on society, like indirect costs and loss of productivity, should be included to accurately map expenditures. Also, health and financial implications for family and proxies deserve investigation. Last, the use of accurate cost calculation methods using exact healthcare consumption and cost price data could further improve the accuracy of cost calculations and thus outcome results. [88, 89] 
Conclusions
We conclude that healthcare consumption and in-hospital costs for patients with s-TBI are generally high. In-hospital costs mostly consist of costs related to LOS and surgical interventions. The major variation of study results is primarily caused by methodological and clinical heterogeneity. Study quality was variable but often inadequate and especially items considered important in calculation and reporting of in-hospital costs scored poorly. High quality future economic evaluations could guide physicians and policy-maker in improving clinical decision-making and resource allocation. Studies should therefore focus on the long-term costeffectiveness of treatments and improve both study quality and equality by using guidelines and common data elements. 
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